NeuroOne Medical Technologies Corporation (NMTC)

NMTC Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Net Income	-6.83	-3.61	-12.32	-11.86	-10	-9.95
Depreciation & Amortization	0.26	0.26	0.25	0.2	0.12	0.08
Stock-Based Compensation	1.28	1.26	1.34	1.11	0.95	1.79
Other Adjustments	-0.33	-0.33	0.67	0.1	0.2	-0.02
Change in Receivables	-0.29	-1.09	-0.18	0.03	0.02	-0.05
Changes in Inventories	0.25	0.4	-0.91	-1.02	-0.61	-0.1
Changes in Accounts Payable	-0.19	0.24	0.07	-0.25	0.52	-0.35
Changes in Accrued Expenses	-0.21	-0.05	0.02	-1.23	1.43	-0.01
Changes in Other Operating Activities	-0.02	-	-	0.03	-0.15	-0.01
Operating Cash Flow	-6.16	-2.84	-11.01	-12.89	-7.52	-8.6
Capital Expenditures	-0.1	-0.08	-0.12	-0.38	-0.28	-0.07
Sale of Property, Plant & Equipment	-	-	-	0.01	-	-
Purchases of Investments	-	-	-	-1.47	-3.47	-
Proceeds from Sale of Investments	-	-	-	4.5	0.5	-
Investing Cash Flow	-0.1	-0.08	-0.12	2.65	-3.24	-0.07
Issuance of Common Stock	9.58	9.68	7.68	8.59	13.35	12.79
Repurchase of Common Stock	-0.12	-0.12	-0.08	-0.12	-	-
Net Common Stock Issued (Repurchased)	9.46	9.56	7.6	8.47	13.35	12.79
Other Financing Activities	-1.13	-1.53	-0.33	-1.07	-1.33	-1.25
Financing Cash Flow	8.69	8.03	7.27	7.4	12.02	11.53
Net Cash Flow	2.43	5.11	-3.86	-2.84	1.26	2.86
Free Cash Flow	-6.26	-2.92	-11.13	-13.27	-7.79	-8.67
FCF Margin	-71.81%	-24.13%	-322.39%	-389.45%	-367.67%	-3568.48%
Free Cash Flow Per Share	-	-	-0.42	-0.73	-0.49	-0.81
Levered Free Cash Flow	-5.39	-2.84	-13.02	-14.51	-8.96	-10.4
Unlevered Free Cash Flow	-7.64	-3.46	-12.59	-14.6	-8.99	-10.67

Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q